Commission Implementing Decision (EU) 2026/1089 of 20 May 2026 postponing the expiry date of the approval of medetomidine for use in biocidal products of product-type 21 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council
Proposed act with possible EEA relevance
Act under scrutiny by EEA EFTA
Draft Joint Committee Decision (JCD) under consideration
Entry into force of Joint Committee Decision (JCD) pending
Incorporated into the EEA Agreement and in force
Incorporated into the EEA Agreement but no longer in force
Legal status
EU legal act incorporated into the EEA Agreement by a Joint Committee Decision (JCD)
Area (EEA Agreement)
II Technical Regulations, Standards, Testing and Certification
II.XV Dangerous Substances
Joint committee decision (JCD)
256/2026
In force in the EEA
Yes
Legal Documents
Commission Implementing Decision (EU) 2026/1089 of 20 May 2026 postponing the expiry date of the approval of medetomidine for use in biocidal products of product-type 21 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council
Durchführungsbeschluss (EU) 2026/1089 der Kommission vom 20. Mai 2026 zur Verschiebung des Ablaufdatums der Genehmigung von Medetomidin zur Verwendung in Biozidprodukten der Produktart 21 gemäß der Verordnung (EU) Nr. 528/2012 des Europäischen Parlaments und des Rates
History
Disclaimer: EEA-Lex is provided for information purposes only. The information is not guaranteed or promised to be current or complete and is not intended to replace any applicable legal sources.